Literature DB >> 3319810

Adaptive responses to pharmacological inhibition of small intestinal alpha-glucosidases in the rat.

B Lembcke1, C Löser, U R Fölsch, J Wöhler, W Creutzfeldt.   

Abstract

Intestinal adaptation (small intestinal weight and length, weight of the caecum and of the residual colon) to feeding different doses (0-5-50-500 mg/kg bw) of the absorbable, competitive alpha-glucosidase inhibitors BAY m 1099 and BAY o 1248 for three, seven, or 28 days was studied in rats. With the highest dose of either inhibitor, a significant and time dependent growth of the caecum was observed. Under these conditions, caecal tissue polyamine concentrations (spermidine and spermine) were slightly higher after three, unaffected after seven and slightly decreased after 28 days. Comparing the trophic effect both of BAY m 1099 and BAY o 1248 with that of the almost unabsorbed glucosidase inhibitor acarbose in fed rats showed that caecal weight was higher in response to the absorbed compounds than in response to acarbose, while total caecal carbohydrate content was unaffected by the absorbed and about nine fold increased by the unabsorbed inhibitors. These findings suggest that acarbose may partially inhibit bacterial carbohydrate degradation in the caecum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319810      PMCID: PMC1434562          DOI: 10.1136/gut.28.suppl.181

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Effects of feeding diets containing lactose, agar, cellulose, raw potato starch or arabinose on the dry weights of cleaned gastrointestinal tract organs in the rat.

Authors:  J E FISCHER
Journal:  Am J Physiol       Date:  1957-03

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

3.  Enzymatic activity of "high-mannose" glycosylated forms of intestinal microvillar hydrolases.

Authors:  H Sjöström; O Norén; E M Danielsen
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-12       Impact factor: 2.839

4.  Inhibition of intestinal epithelial DNA synthesis and adaptive hyperplasia after jejunectomy in the rat by suppression of polyamine biosynthesis.

Authors:  G D Luk; S B Baylin
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

5.  Effects of two new alpha-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus.

Authors:  G Dimitriadis; S Raptis; A Raptis; E Hatziagelaki; A Mitrakou; P Halvatsiotis; S Ladas; I Hillebrand
Journal:  Klin Wochenschr       Date:  1986-05-02

6.  Polyamines and intestinal growth--increased polyamine biosynthesis after jejunectomy.

Authors:  G D Luk; S B Baylin
Journal:  Am J Physiol       Date:  1983-11

7.  Absorption of short-chain fatty acids by the colon.

Authors:  H Ruppin; S Bar-Meir; K H Soergel; C M Wood; M G Schmitt
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

8.  Analysis of dansyl derivatives of di- and polyamines in mouse brain, human serum and duodenal biopsy specimens by high-performance liquid chromatography on a standard reversed-phase column.

Authors:  J Bontemps; J Laschet; G Dandrifosse; J L Van Cutsem; P P Forget
Journal:  J Chromatogr       Date:  1984-11-09

9.  Colonic metabolism of wheat starch in healthy humans. Effects on fecal outputs and clinical symptoms.

Authors:  B Flourie; C Florent; J P Jouany; P Thivend; F Etanchaud; J C Rambaud
Journal:  Gastroenterology       Date:  1986-01       Impact factor: 22.682

10.  Long-term feeding of unavailable carbohydrate gelling agents. Influence of dietary concentration and microbiological degradation on adaptive responses in the rat.

Authors:  B Elsenhans; R Blume; W F Caspary
Journal:  Am J Clin Nutr       Date:  1981-09       Impact factor: 7.045

View more
  1 in total

1.  Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers.

Authors:  B Lembcke; U R Fölsch; W Gatzemeier; B Lücke; R Ebert; E Siegel; W Creutzfeldt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.